Skip to main content
Skip to section navigation
Skip to footer
Medical Professionals
Information for Healthcare Providers
Clinical Studies
Expanded Access
Educational Grants
Request Information
Press Releases
Suppliers
Atara Biotherapeutics
Our Company
About Us
Responsibility
Technology
Pipeline
Atara Pipeline
Tab-cel
®
ATA188
ATA3219
ATA2271/ATA3271
Patients & Families
Our Mission
Stories of Strength
About EBV
PTLD
Multiple Sclerosis
Clinical Studies
Expanded Access
Investors & Media
Investors & Media
News & Events
Financial Results
ATRA Stock
Analyst Coverage
SEC Filings
Governance
Careers
Careers Home
Career Areas
Job Search
Contact
Medical Professionals
Press Releases
Suppliers
LinkedIn
Twitter
News
Careers
Investors & Media
Investors & Media
Investors & Media
News & Events
Overview
Press Releases
Events
Presentations
Email Alerts
Investor & Media Contacts
Financial Results
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
ATRA Stock
Overview
Charts
Historical Data
FAQ
Classification Info
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Investor Relations
News & Events
Presentations
Nov 1, 2023
Investor Presentation
rss_feed
RSS
Email Alerts
Contacts
RSS News Feed
